Simcere Pharmaceutical Income Statement

2096 HK$8.12 -0.1 -1.5%

8:08am

Highly Speculative, Mid Cap, Style Neutral

Market Cap £1.99bn

Enterprise Value £2.34bn

Revenue £504.0m

Quality

Value

Momentum

StockRank™

To unlock Simcere Pharmaceutical's income statement please upgrade your membership.

	2017	2018	2019
Period End:	2017-12-31	2018-12-31	2019-12-31
Period Length:	12M	12M	12M
Currency:	CNY	CNY	CNY

Revenue
Total Revenue

Cost of Revenue, Total
Gross Profit

Selling/General/Administrative Expenses, Total
Research & Development
Unusual Expense (Income)
Other Operating Expenses, Total

Total Operating Expense
Operating Profit/Income

Total Non Operating Interest Expense
Income Before Tax
Income Tax - Total
Income After Tax

Minority Interest
Net Income Before Extra. Items
Net Income

Income Available to Common Excl. Extra. Items
Income Available to Common Incl. Extra. Items
Diluted Net Income
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Incl. Extraordinary Items
Diluted EPS Excluding Extraordinary Items

Normalized Income Before Taxes
Normalized Income After Taxes
Normalized Inome Avail to Common Stock
Diluted Normalized EPS

Unlock Stockopedia Premium for free!

See what it can do for your stockpicking and portfolio at no expense.